<DOC>
	<DOCNO>NCT01103063</DOCNO>
	<brief_summary>The primary objective establish superiority AZCQ SP protective efficacy IPTp measure proportion subject sub-optimal pregnancy outcome .</brief_summary>
	<brief_title>Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa</brief_title>
	<detailed_description>After interim analysis efficacy data External Data Monitoring Committee , study terminate . Investigators notify 22 Aug 2013 . There safety concern lead termination .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<criteria>Pregnant woman ( gravidae ) ≥14 ≤26 week gestational age ( ultrasound ) . Evidence personally sign date informed consent/assent document . Assent obtain subject &lt; 18 year age . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Subjects available follow delivery 28 day post delivery . Age &lt; 16 year old &gt; 35 year old . Multiple gestation per ultrasound screening . Clinical symptom malaria . Hemoglobin &lt; 8 g/dL ( enrollment ) . Any condition require hospitalization enrollment . History convulsion , hypertension , diabetes chronic illness may adversely affect fetal growth viability . Inability tolerate oral treatment tablet form . Known allergy study drug ( azithromycin , chloroquine , sulfadoxinepyrimethamine ) macrolides sulphonamides . Requirement use medication study might interfere evaluation study drug eg , trimethoprimsulfamethoxazole use subject positive HIV infection . Other severe acute chronic medical psychiatric condition laboratory abnormality may increase risk associate study participation . Evidence current obstetric complication may adversely impact pregnancy and/or fetal outcome , include presence congenital anomaly , placenta previa abruption . Known severe Sickle Cell ( SS ) disease Sickle Hemoglobin C ( SC ) anemia . Known family history prolong QT Syndrome , serious ventricular arrhythmia , sudden cardiac death .</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>P. falciparum malaria</keyword>
	<keyword>IPTp</keyword>
</DOC>